Non-viral vectors need to overcome several barriers such as the plasma membrane, the endosomal membrane and the nuclear membrane for e‹cient gene delivery to the nucleus of target cells. To overcome these obstacles, the delivery system must be equipped with various functional devices. However, it is di‹cult to package all these needed devices into a single system to exert each of their functions at the appropriate time and at the correct location. Thus, our group proposed a new packaging concept,``Programmed Packaging''. A multifunctional envelope-type nano device (MEND) was developed for use as an e‹cient non-viral system for the delivery of plasmid DNA (pDNA), oligodeoxynucleotide (ODN) and siRNA. Various types of MEND were developed as to strategy and situations. For example, the octaarginine (R8)-modiˆed MEND (R8-MEND) encapsulating pDNA showed signiˆcantly high transfection activity comparable to adenovirus, and the up-take pathway of the R8-MEND was macropinocytosis, which can avoid lysosomal degradation. The R8-MEND successfully delivered a gene to hair follicles of mouse skin by in vivo topical application. Consequently, our group succeeded in the development of the MEND based on the Programmed Packaging, and found this to be a promising new delivery system of pDNA and functional nucleic acids.
The MEND consists of condensed nucleotides core, coated with a lipid envelope equipped with functional devices, such as polyethylene glycol (PEG) for long blood circulation, pH-sensitive fusogenic peptide for endosomal escape and protein transduction domain peptide for cellular entry. In this method, a condensed DNA core particle electrostatically adsorb to surface of lipidˆlm, then the core particle is coated with lipid membrane by gentle sonication. After lipid coating, the MEND can be modiˆed with functional devices, such as STR-R8. The transfection e‹ciencies of R8-MEND and Adenovirus were compared using HeLa cell lines that express receptors for adenovirus serotype 5 (i.e., CAR and the integrin receptor). Increasing the dose of Adenovirus up to 1×10 5 particles/cell resulted in higher transfection e‹ciency; however, toxicity increased and transfection e‹ciency decreased at doses higher than 1 ×10 5 particles/cell. Transfection e‹ciency with R8-MEND equaled the highest transfection e‹ciency with Adenovirus, however, R8-MEND produced no detectable cytotoxicity (data not shown). 
